OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

New call for tenders to be launched & suppliers information day 29/06/2022

New call for tenders to be launched & suppliers information day 29/06/2022
2022-06-22
by Editorial team

The OncNGS consortium launched a Call for Tender in December 2021. Due to some unforeseen circumstances, the current Tender procedure is closed and a new Call for Tender will be launched soon.
These unforeseen circumstances gave us the opportunity to make some changes to the oncNGS tender documents.

In this regard, we are organizing an oncNGS Suppliers Information day to be held on June 29 from 5 to 6:30 pm. During this session we will update you on the Call for Tender text updates that have been put in place compared to previous version

Register here for the suppliers information day!

For the OncNGS buyers group this is a strategic procurement: suppliers successful to deliver OncNGS pre-commercial solutions will have the opportunity to completely transform cancer patients experience increasing OncNGS buyers’ diagnosis, prognosis and theranosis capabilities. The implemented modification to the tender documents are expected to strengthen these opportunities.

Stay tuned for more information! Follow us on Twitter, join our network on LinkedIn!

Update 04/07/2022: The recording and presentation of the oncNGS suppliers information day are now available! Learn more.

Share us on:
  • Home
  • About
  • Phases
  • Open Market Consultation
  • News
  • Contact
  • Login
  • FAQ

Articles récents

  • OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing
  • oncNGS consortium conducted site visits to phase 2 contractors
  • OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer
  • Update on the current stage of the oncNGS Pre-Commercial Procurement procedure
  • The oncNGS consortium selects 4 innovative ideas for the research and development of Next Generation Sequencing solutions for cancer tests

Archives

  • janvier 2025
  • mai 2024
  • septembre 2023
  • février 2023
  • juillet 2022
  • juin 2022
  • mars 2022
  • janvier 2022
  • décembre 2021
  • novembre 2021
  • septembre 2021
  • août 2021
  • juin 2021
  • mai 2021
  • avril 2021
  • mars 2021

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer